Cabaletta Bio, Inc. - CABA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$245.1M

QoQ value delta ($000)

+$87.95M (+55.95%)

Implied price effect (QoQ)

+21.45%

Total shares

92,207,029

QoQ shares delta

+20,396,794 (+28.4%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 112 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
T. Rowe Price Investment Management, Inc.	29,806	11,080,005	0.02%
Bain Capital Life Sciences Investors, LLC	26,031	9,677,125	2.35%
JENNISON ASSOCIATES LLC	24,130	8,970,578	0.02%
ADAGE CAPITAL PARTNERS GP, L.L.C.	23,752	8,829,758	0.04%
MILLENNIUM MANAGEMENT LLC	15,879	5,903,281	0.01%
Cormorant Asset Management, LP	14,795	5,500,000	0.74%
VANGUARD CAPITAL MANAGEMENT LLC	10,837	4,028,991	0.0%
VANGUARD GROUP INC	9,678	4,419,458	0.0%
TWO SIGMA INVESTMENTS, LP	6,719	2,497,917	0.01%
BlackRock, Inc.	6,383	2,373,003	0.0%
MARSHALL WACE, LLP	5,863	2,179,818	0.01%
RENAISSANCE TECHNOLOGIES LLC	5,478	2,036,663	0.01%
Qube Research & Technologies Ltd	5,205	1,934,990	0.01%
MORGAN STANLEY	3,787	1,408,152	0.0%
Opaleye Management Inc.	3,712	1,380,000	0.49%
Woodline Partners LP	3,363	1,250,242	0.01%
GEODE CAPITAL MANAGEMENT, LLC	3,049	1,133,245	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	3,002	1,116,100	0.0%
SUPERSTRING CAPITAL MANAGEMENT LP	2,868	1,066,239	2.05%
GOLDMAN SACHS GROUP INC	2,769	1,029,720	0.0%
Ikarian Capital, LLC	2,421	900,000	0.2%
CANTOR FITZGERALD, L. P.	2,057	765,000	0.03%
DIMENSIONAL FUND ADVISORS LP	1,990	740,648	0.0%
Burkehill Global Management, LP	1,883	700,000	0.09%
SCHRODER INVESTMENT MANAGEMENT GROUP	1,868	756,637	0.0%